Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Stevens-Johnson Syndrome and CYP2C9[original query] |
---|
Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 2014 Aug 312 (5): 525-34. Chung Wen-Hung, Chang Wan-Chun, Lee Yun-Shien, Wu Ying-Ying, Yang Chih-Hsun, Ho Hsin-Chun, Chen Ming-Jing, Lin Jing-Yi, Hui Rosaline Chung-Yee, Ho Ji-Chen, Wu Wei-Ming, Chen Ting-Jui, Wu Tony, Wu Yih-Ru, Hsih Mo-Song, Tu Po-Hsun, Chang Chen-Nen, Hsu Chien-Ning, Wu Tsu-Lan, Choon Siew-Eng, Hsu Chao-Kai, Chen Der-Yuan, Liu Chin-San, Lin Ching-Yuang, Kaniwa Nahoko, Saito Yoshiro, Takahashi Yukitoshi, Nakamura Ryosuke, Azukizawa Hiroaki, Shi Yongyong, Wang Tzu-Hao, Chuang Shiow-Shuh, Tsai Shih-Feng, Chang Chee-Jen, Chang Yu-Sun, Hung Shuen-Iu, , |
[Predictive genomic markers for severe adverse drug reactions]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2015 135 (4): 589-95. Saito Yoshiro, Kodama Susumu, Sugiyama Emiko, Nakamura Ryosu |
Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. Pharmacogenetics and genomics 2016 May 26 (5): 225-34. Tassaneeyakul Wichittra, Prabmeechai Napat, Sukasem Chonlaphat, Kongpan Thachanan, Konyoung Parinya, Chumworathayi Pansu, Tiamkao Somsak, Khunarkornsiri Usanee, Kulkantrakorn Kongkiat, Saksit Niwat, Nakkam Nontaya, Satapornpong Patompong, Vannaprasaht Suda, Sangviroon Alisara, Mahasirimongkol Surakameth, Wichukchinda Nuanjun, Rerkpattanapipat Ticha, Tassaneeyakul Wongwiw |
Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions. European journal of clinical pharmacology 2017 Apr . Yampayon Kittika, Sukasem Chonlaphat, Limwongse Chanin, Chinvarun Yotin, Tempark Therdpong, Rerkpattanapipat Ticha, Kijsanayotin Pornpim |
Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics 2018 Jun 43 (3): 408-413. Wu X, Liu W, Zhou |
CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment. Pharmacogenomics and personalized medicine 2018 4 11 51-58. Silvado Carlos Eduardo, Terra Vera Cristina, Twardowschy Carlos Alexand |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. Clinical pharmacology and therapeutics 2020 Aug . Karnes Jason H, Rettie Allan E, Somogyi Andrew A, Huddart Rachel, Fohner Alison E, Formea Christine M, Ta Michael Lee Ming, Llerena Adrian, Whirl-Carrillo Michelle, Klein Teri E, Phillips Elizabeth J, Mintzer Scott, Gaedigk Andrea, Caudle Kelly E, Callaghan John |
Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. Clinical pharmacology and therapeutics 2020 May . Sukasem Chonlaphat, Pratoomwun Jirawat, Satapornpong Patompong, Klaewsongkram Jettanong, Rerkpattanapipat Ticha, Rerknimitr Pawinee, Lertpichitkul Pattamon, Puangpetch Apichaya, Nakkam Nontaya, Konyoung Parinya, Khunarkornsiri Usanee, Disphanurat Wareeporn, Srisuttiyakorn Chutika, Pattanacheewapull Oranuch, Kanjanawart Sirimas, Kongpan Thachanan, Chumworathayi Pansu, Saksit Niwat, Bruminhent Jackrapong, Tassaneeyakul Wichittra, Chantratita Wasun, Pirmohamed Munir, |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: